Bacterial trial fails to demonstrate early asthma prevention
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 03:16 ET (26-Oct-2026 07:16 GMT/UTC)
A working prototype that can see, remember and interact with the world like the human brain could one day underpin smart bionic eyes, while using far less energy than today's technologies.
The invention from RMIT University combines sensing, memory and information processing within the same system, reducing the need to constantly move data between separate sensors, memory banks and processors.
While still an early-stage research demonstration, the neuromorphic vision innovation could dramatically reduce the amount of data and energy required to perform complex visual tasks.
Wastewater and environmental surveillance (WES) – the analysis of water and environmental samples like sewage to enable early, non-invasive tracking of biological and chemical markers across a population – is a powerful and increasingly common public health tool. When paired with clinical data, it offers a real-time window into community health that can inform faster, more targeted responses to infectious disease. However, its use in carceral settings like jails and prisons remains ethically underexamined.
In a brief analytic essay in the American Journal of Public Health, a team comprised of Boston University and University of Louisville researchers found that carceral WES is neither fully covered by human subjects protections nor fully accountable to traditional public health guidelines, producing a fragmented regulatory landscape in which some safeguards impede informed and effective research while others fail to prevent misuse or harm to incarcerated individuals and surrounding communities.
In a new NIH-supported study in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association, researchers detected significant risk associations for vascular and Alzheimer’s dementias among American Indians for four previously-identified key risk factors: limited education, hypertension, social isolation, and depression.
The VCU and Pitt-led study is the first of its kind in the United States to assess the cardiovascular impact of hormone therapy during perimenopause.